Dr. Vanja Christopher Douglas, MD

Dr. Douglas practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Douglas' NPI, 1417087784, was assigned on March 6, 2007. Dr. Douglas graduated from UCSF School of Medicine in 2004. Dr. Douglas holds California license A94749.

Dr. Douglas' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Douglas' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Douglas is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Douglas to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Douglas practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Douglas' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Douglas is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Douglas is licensed in California.

Dmand AI lists epilepsy, head injury, seizures and stroke among the conditions Dr. Douglas treats.

CMS data shows 453 Medicare services from Dr. Douglas across 6 procedure codes in 2024, for 245 Medicare patients. Medicare paid $57,544 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 245 Medicare patients who saw Dr. Douglas in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Douglas' median patient age at 62, with 46% women.

In 2024, Dr. Douglas wrote 67 Medicare Part D claims for 15 patients. 73% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $13,038 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Douglas for performance year 2024, reported as part of a group. Dr. Douglas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Douglas as offering telehealth.

Dmand AI links 60 papers to Dr. Douglas, published from 2003 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Delirium, Magnetic Resonance Imaging and Predictive Value of Tests. Dr. Douglas has published most often in Neurohospitalist. Dr. Douglas' most frequent co-authors are Scott A. Josephson, MD, Sara Lahue, MD and Maulik Pradeep Shah, MD.

Dr. Douglas graduated from UCSF School of Medicine in 2004.

Dr. Douglas is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.